Pharmaceutical giant faces a growing list of questions from investors and regulators
The Bottom Line: a little communication with shareholders would go a long way
Valeant Pharmaceuticals is a drug company that doesn’t develop drugs – it runs a serial takeover operation
Canadian pharma firm teams up with Wall Street hedge fund mogul to mount hostile takeover of Allergan
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices